Dr Lynn Drummond elected fellow of Royal Society of Edinburgh
This article was originally published in Scrip
The Royal Society of Edinburgh has elected Dr Lynn Drummond as a fellow. She is an executive managing director in the investment banking division of Rothschild, and also serves as non-executive director at Alimentary Health and chairman of the charity Breast Cancer Haven.
You may also be interested in...
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.
Pink Sheet analysis finds that evidence from early-stage trials supports most BTD requests, but about three in 10 designations are granted on the basis of pivotal-stage data.
Four House hearings show how far away even many Democrats are from supporting a single payer system in the US.